U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Elam Nevan C (0001314773)
Mailing Address
C/O NEKTAR THERAPEUTICS
150 INDUSTRIAL ROAD
SAN CARLOS CA 94070
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Rezolute, Inc. 0001509261 2024-01-23 director, officer: CEO
Peak Bio, Inc. 0001834645 2022-11-01 director
Savara Inc 0001160308 2017-04-27 director
NEKTAR THERAPEUTICS 0000906709 2005-01-17 officer: General Counsel and Secretary


Items 1 - 72

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2025-03-27   Rezolute, Inc. 4 P-Purchase --D 12302.0000 224119.0000 1 0001509261 Common Shares
A 2025-02-16   Rezolute, Inc. 4 A-Award --D 120000.0000 120000.0000 2 0001509261 Employee Stock Option (Right to Buy)
A 2025-02-16   Rezolute, Inc. 4 A-Award --D 204000.0000 211817.0000 1 0001509261 Common Shares
A 2024-12-12 2024-12-12 Savara Inc 4 A-Award --D 40000.0000 62500.0000 1 0001160308 Common Stock
A 2024-02-26   Rezolute, Inc. 4 P-Purchase --D 5000.0000 7817.0000 1 0001509261 Common Shares
A 2024-01-23   Rezolute, Inc. 4 A-Award --D 340000.0000 340000.0000 1 0001509261 Employee Stock Options (Right to Buy)
D 2023-12-28   Savara Inc 4 M-Exempt --D 1758.0000 0.0000 5 0001160308 Stock Option (Right to Buy)
A 2023-12-28   Savara Inc 4 M-Exempt --D 1758.0000 64343.0000 1 0001160308 Common Stock
A 2023-12-28   Savara Inc 4 M-Exempt --D 12000.0000 76343.0000 2 0001160308 Common Stock
A 2023-12-28   Savara Inc 4 M-Exempt --D 40000.0000 116343.0000 3 0001160308 Common Stock
D 2023-12-28   Savara Inc 4 S-Sale --D 93843.0000 22500.0000 4 0001160308 Common Stock
D 2023-12-28   Savara Inc 4 M-Exempt --D 12000.0000 0.0000 6 0001160308 Stock Option (Right to Buy)
D 2023-12-28   Savara Inc 4 M-Exempt --D 40000.0000 0.0000 7 0001160308 Stock Option (Right to Buy)
A 2023-12-14   Savara Inc 4 A-Award --D 22500.0000 62585.0000 1 0001160308 Common Stock
D 2023-12-11   Savara Inc 4 M-Exempt --D 10841.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2023-12-11   Savara Inc 4 M-Exempt --D 10841.0000 40085.0000 1 0001160308 Common Stock
A 2022-12-13   Savara Inc 4 A-Award --D 40000.0000 40000.0000 3 0001160308 Stock Option (Right to Buy)
A 2022-12-13   Savara Inc 4 M-Exempt --D 1172.0000 29244.0000 1 0001160308 Common Stock
D 2022-12-13   Savara Inc 4 M-Exempt --D 1172.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2022-06-23   Rezolute, Inc. 4 A-Award --D 2600000.0000 2600000.0000 1 0001509261 Stock Option (right to buy)
A 2021-12-14   Savara Inc 4 A-Award --D 40000.0000 40000.0000 1 0001160308 Stock Option (Right to Buy)
D 2021-12-06   Savara Inc 4 M-Exempt --D 1172.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2021-12-06   Savara Inc 4 M-Exempt --D 1172.0000 28072.0000 1 0001160308 Common Stock
D 2021-08-18   Savara Inc 4 M-Exempt --D 2288.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2021-08-18   Savara Inc 4 M-Exempt --D 2288.0000 26900.0000 1 0001160308 Common Stock
D 2021-06-14   Rezolute, Inc. 4/A D-Return --D 100000.0000 575000.0000 4 0001509261 Stock Option (right to buy)
A 2021-06-14   Rezolute, Inc. 4/A A-Award --D 375000.0000 675000.0000 3 0001509261 Stock Option (right to buy)
D 2021-06-14   Rezolute, Inc. 4/A D-Return --D 70000.0000 0.0000 2 0001509261 Stock Option (right to buy)
D 2021-06-14   Rezolute, Inc. 4/A D-Return --D 34800.0000 0.0000 1 0001509261 Stock Option (right to buy)
D 2021-06-14   Rezolute, Inc. 4 D-Return --D 100000.0000 575000.0000 4 0001509261 Stock Option (right to buy)
A 2021-06-14   Rezolute, Inc. 4 A-Award --D 375000.0000 675000.0000 3 0001509261 Stock Option (right to buy)
D 2021-06-14   Rezolute, Inc. 4 D-Return --D 70000.0000 0.0000 2 0001509261 Stock Option (right to buy)
D 2021-06-14   Rezolute, Inc. 4 D-Return --D 34800.0000 0.0000 1 0001509261 Stock Option (right to buy)
A 2020-12-16   Savara Inc 4 A-Award --D 40000.0000 40000.0000 3 0001160308 Stock Option (Right to Buy)
D 2020-12-15   Savara Inc 4 M-Exempt --D 2930.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2020-12-15   Savara Inc 4 M-Exempt --D 2930.0000 24612.0000 1 0001160308 Common Stock
A 2019-12-20   Savara Inc 4 A-Award --D 12000.0000 12000.0000 1 0001160308 Stock Option (Right to Buy)
A 2019-07-31   Rezolute, Inc. 4 A-Award --D 15000000.0000 15000000.0000 1 0001509261 Stock Option (right to buy)
D 2019-02-04   Savara Inc 4 M-Exempt --D 21682.0000 0.0000 2 0001160308 Stock Option (Right to Buy)
A 2019-02-04   Savara Inc 4 M-Exempt --D 21682.0000 21682.0000 1 0001160308 Common Stock
A 2018-12-13   Savara Inc 4 A-Award --D 12000.0000 12000.0000 1 0001160308 Stock Option (Right to Buy)
A 2017-12-17   Savara Inc 4 A-Award --D 3750.0000 3750.0000 1 0001160308 Stock Option (Right to Buy)
A 2016-10-31   AntriaBio, Inc. 4 A-Award --D 3500000.0000 3500000.0000 1 0001509261 Stock Option (right to buy)
A 2015-12-10   AntriaBio, Inc. 4 P-Purchase --D 76923.0000 76923.0000 3 0001509261 Series A Convertible Preferred Stock
D 2015-02-09   AntriaBio, Inc. 4 S-Sale --I 842949.0000 0.0000 1 0001509261 Common Stock
D 2015-02-09   AntriaBio, Inc. 4 S-Sale --I 39117.0000 0.0000 2 0001509261 Warrant to Purchase Common Stock
A 2014-04-30   AntriaBio, Inc. 4 A-Award --D 1350000.0000 4850000.0000 1 0001509261 Stock Option (right to buy)
A 2014-03-31   AntriaBio, Inc. 4 A-Award --I 1057693.0000 5057693.0000 1 0001509261 Common Stock
A 2014-03-31   AntriaBio, Inc. 4 J-Other --I 234700.0000 234700.0000 2 0001509261 Warrant to purchase common stock
A 2008-02-25   NEKTAR THERAPEUTICS 4 A-Award --D 85000.0000 85000.0000 1 0000906709 Employee Stock Option
A 2007-12-21   NEKTAR THERAPEUTICS 4 A-Award --D 150000.0000 150000.0000 1 0000906709 Employee Stock Option
A 2007-05-14   NEKTAR THERAPEUTICS 4 A-Award --D 1400.0000 1400.0000 1 0000906709 Common Stock
D 2007-05-14   NEKTAR THERAPEUTICS 4 D-Return --D 1400.0000 5600.0000 2 0000906709 Restricted Stock Unit
A 2007-04-02   NEKTAR THERAPEUTICS 4 A-Award --D 40000.0000 132000.0000 1 0000906709 Stock Option (Right to Buy)
A 2006-09-01   NEKTAR THERAPEUTICS 4 A-Award --D 12000.0000 92000.0000 1 0000906709 Stock Option (Right to Buy)
A 2006-03-10   NEKTAR THERAPEUTICS 4 A-Award --D 7000.0000 7000.0000 1 0000906709 Restricted Stock Unit
A 2005-01-17   NEKTAR THERAPEUTICS 4/A A-Award --D 80000.0000 0.0000 1 0000906709 Employee Stock Option (Right to Buy)
A 2005-01-17   NEKTAR THERAPEUTICS 4 A-Award --D 80000.0000 0.0000 1 0000906709 Employee Stock Option (Right to Buy)
- -   Peak Bio, Inc. 3 - --- 1 - -
- -   Savara Inc 3 - --D 1 0001160308 Stock Option (Right to Buy)
- -   AntriaBio, Inc. 3 - --D 2 0001509261 Option to Purchase Common Stock
- -   AntriaBio, Inc. 3 - --I 4000000.0000 1 0001509261 Common Stock
- -   Savara Inc 3 - --D 2 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 3 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 4 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 5 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 6 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 7 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 8 0001160308 Stock Option (Right to Buy)
- -   Savara Inc 3 - --D 9 0001160308 Stock Option (Right to Buy)
- -   NEKTAR THERAPEUTICS 3/A - --D 1 0000906709 Employee Stock Option (Right to Buy)
- -   NEKTAR THERAPEUTICS 3 - --D 1 0000906709 Employee Stock Option (Right to Buy)

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016